Marc Stapley Biography and Net Worth

CEO of Veracyte

Marc Stapley joined Veracyte in 2021 as Chief Executive Officer and a member of the company’s board of directors. Mr. Stapley has deep experience in the genomic diagnostics industry, including significant expertise building and leading complex global enterprises. Prior to Veracyte, he served as Chairman and Chief Executive Officer of Helix, a leading population genomics company, from 2019 to 2021. Under Mr. Stapley’s leadership, Helix built one of the largest COVID-19 testing labs in the United States and became a national leader in viral surveillance. Prior to Helix, Mr. Stapley served in key executive leadership positions at Illumina from 2012 to 2019, including as Chief Financial Officer, Chief Administrative Officer and Executive Vice President, where he led many functions including G&A, corporate strategy, business development, population genomics and government affairs. Prior to Illumina, Mr. Stapley was Senior Vice President, Finance, at Pfizer Inc. and before that, he served in a variety of senior finance roles at Alcatel-Lucent, Cadence Design Systems, Inc., and Coopers & Lybrand (now PwC). He currently serves as a member of the board of directors of Helix and Glaukos. Mr. Stapley holds a B.Sc. (Honors) in Mathematics from the University of Reading (England).

What is Marc Stapley's net worth?: The estimated net worth of Marc Stapley is at least $15.84 million as of September 4th, 2025. Stapley owns 334,185 shares of Veracyte stock worth more than $15,843,711 as of December 4th. This net worth evaluation does not reflect any other assets that Stapley may own. Additionally, Stapley receives an annual salary of $1,550,000.00 as CEO at Veracyte. Learn More about Marc Stapley's net worth.
How old is Marc Stapley?: Stapley is currently 54 years old. There are 6 older executives and no younger executives at Veracyte. Learn More on Marc Stapley's age.
What is Marc Stapley's salary?: As the CEO of Veracyte, Inc., Stapley earns $1,550,000.00 per year. Learn More on Marc Stapley's salary.
How do I contact Marc Stapley?: The corporate mailing address for Stapley and other Veracyte executives is 6000 SHORELINE COURT SUITE 300, SOUTH SAN FRANCISCO CA, 94080. Veracyte can also be reached via phone at (650) 243-6300 and via email at [email protected]. Learn More on Marc Stapley's contact information.
Has Marc Stapley been buying or selling shares of Veracyte?: Marc Stapley has not been actively trading shares of Veracyte during the past quarter. Most recently, Marc Stapley sold 7,667 shares of the business's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $30.41, for a transaction totalling $233,153.47. Following the completion of the sale, the chief executive officer now directly owns 334,185 shares of the company's stock, valued at $10,162,565.85. Learn More on Marc Stapley's trading history.
Who are Veracyte's active insiders?: Veracyte's insider roster includes Bonnie Anderson (Insider), Muna Bhanji (Director), Rebecca Chambers (Exec. VP & CFO ), Rebecca Chambers (CFO), Karin Eastham (Director), Phillip Febbo (Insider), Jens Holstein (Director), Evan Jones (Director), Giulia Kennedy (Insider), John Leite (Chief Commercial Officer, CLIA Business), Annie Mcguire (SVP), Marc Stapley (CEO), Marc Stapley (CEO & Director), Jonathan Wygant (CAO), and Jonathan Wygant (CAO). Learn More on Veracyte's active insiders.
Are insiders buying or selling shares of Veracyte?: In the last year, insiders at the biotechnology company sold shares 12 times. They sold a total of 109,076 shares worth more than $4,535,689.41. The most recent insider tranaction occured on November, 25th when insider John Leite sold 2,808 shares worth more than $140,400.00. Insiders at Veracyte own 1.4% of the company. Learn More about insider trades at Veracyte.
Information on this page was last updated on 11/25/2025.

Marc Stapley Insider Trading History at Veracyte

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/4/2025	Sell	7,667	$30.41	$233,153.47	334,185
6/10/2022	Buy	60,000	$16.33	$979,800.00	159,761

Marc Stapley Buying and Selling Activity at Veracyte

Veracyte Company Overview

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Today's Range

Now: $47.41

$46.02

$47.78

50 Day Range

MA: $39.11

$33.44

$49.38

2 Week Range

Now: $47.41

$22.61

$50.71

Volume

895,484 shs

Average Volume

974,443 shs

Market Capitalization

$3.75 billion

P/E Ratio

124.77

Dividend Yield

N/A

Beta

1.83

Marc Stapley Biography and Net Worth

What is Marc Stapley's net worth?

How old is Marc Stapley?

What is Marc Stapley's salary?

How do I contact Marc Stapley?

Has Marc Stapley been buying or selling shares of Veracyte?

Who are Veracyte's active insiders?

Are insiders buying or selling shares of Veracyte?